UCP2 and diabetes mellitus: DeSouza et al. (2007) used an antisense oligonucleotide to Ucp2 in ob/ob mice and Swiss mice with hyperlipidemic diet-induced obesity and diabetes to inhibit UCP2 expression, resulting in metabolic improvement [99].